Have a personal or library account? Click to login
Use of Ustekinumab in the Treatment of Libyan Psoriasis Vulgaris Patients Cover

Use of Ustekinumab in the Treatment of Libyan Psoriasis Vulgaris Patients

Serbian Journal of Dermatology and Venereology
Volume 11 (2019): Issue 1 (March 2019)
By: Belkais Beltammer,  Ali Gargoom,  Ghada Taeib and  Gamal Duweb  
Open Access
|Nov 2019

Authors

Belkais Beltammer

Dermatology Department, Faculty of Medicine, Benghazi University, Benghazi, Libya

Ali Gargoom

Dermatology Department, Faculty of Medicine, Benghazi University, Benghazi, Libya

Ghada Taeib

Dermatology Department, Faculty of Medicine, Benghazi University, Benghazi, Libya

Gamal Duweb

drduweb@gmail.com

Dermatology Department, Faculty of Medicine, Benghazi University, Benghazi, Libya
DOI: https://doi.org/10.2478/sjdv-2019-0002 | Journal eISSN: 2406-0631
Journal RSS Feed
Language: English
Page range: 13 - 18
Submitted on: Mar 12, 2019
Accepted on: Mar 19, 2019
Published on: Nov 12, 2019
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Psoriasis,
Ustekinumab,
Dermatologic Agents,
Biological Therapy,
Treatment Outcome,
Libya
Related subjects:
Medicine,
Clinical medicine,
Dermatological and veneral diseases

© 2019 Belkais Beltammer, Ali Gargoom, Ghada Taeib, Gamal Duweb, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 11 (2019): Issue 1 (March 2019)Next article